Abstract
Kaposi’s sarcoma (KS) is a mesenchymal tumour of unclear etiopathogenesis involving blood and lymphatic vessels which was first investigated by Moritz Kaposi in 1872 [2]. Moritz Kaposi described a disease that was and is diagnosed very rarely, predominantly in elderly men in eastern European countries. This so-called classical form of KS typically involves the lower extremities and very seldom visceral organs. The tumours grow slowly, sometimes over many years, from flat purple plaques to nodular lesions involving adjacent lymph nodes [1, 3]. Throughout the past few years much knowledge of the epidemiology and pathogenesis of KS has been gained.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
